Final draft guidance from NICE has backed NHS use of Filspari (sparsentan) for primary immunoglobulin A nephropathy (IgAN), ...

Regeneron Pharmaceuticals said in a press release yesterday that it would acquire 23andMe’s Personal Genome Service (PGS), ...

It has been nearly two months since 23andMe declared bankruptcy and the company has officially been sold. The US biotech company Regeneron has agreed to buy 23andMe and all of its assets for $256 ...

Regeneron Pharmaceuticals on Monday announced plans to purchase genetic testing company 23andMe for $256 million. The New York-based drugmaker is set to take over 23andMe after winning a bankruptcy ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said that ...

Regeneron Pharmaceuticals has agreed to buy 23andMe for $256 million and plans to continue consumer DNA testing services without interruption.

Investing.com -- Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) climbed 2% today following the announcement that the company has won the bid to purchase the assets of 23andMe, a leading human ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

After filing for bankruptcy, 23andMe has found a buyer. New York-based Regeneron will pay $256 million for the California company, which was once valued at $6 billion. Importantly, Regeneron ...

The US’s credit rating took a hit on Friday, after Moody’s downgraded the country’s AAA rating. And then yesterday, bond ...

Investing.com -- Shares of OraSure Technologies Inc (NASDAQ:OSUR) climbed 7.4% today after news that Regeneron Pharmaceuticals (NASDAQ:REGN) has been named the successful bidder in the bankruptcy ...